ATE336512T1 - Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe - Google Patents

Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe

Info

Publication number
ATE336512T1
ATE336512T1 AT99917909T AT99917909T ATE336512T1 AT E336512 T1 ATE336512 T1 AT E336512T1 AT 99917909 T AT99917909 T AT 99917909T AT 99917909 T AT99917909 T AT 99917909T AT E336512 T1 ATE336512 T1 AT E336512T1
Authority
AT
Austria
Prior art keywords
epitopes
detection
envelope proteins
antibodies against
specific antibodies
Prior art date
Application number
AT99917909T
Other languages
English (en)
Inventor
Geert Maertens
Erik Depla
Marie-Ange Buyse
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE336512T1 publication Critical patent/ATE336512T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99917909T 1998-03-27 1999-03-29 Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe ATE336512T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870060A EP0947525A1 (de) 1998-03-27 1998-03-27 Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe

Publications (1)

Publication Number Publication Date
ATE336512T1 true ATE336512T1 (de) 2006-09-15

Family

ID=8237012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99917909T ATE336512T1 (de) 1998-03-27 1999-03-29 Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe

Country Status (19)

Country Link
US (2) US6521403B1 (de)
EP (2) EP0947525A1 (de)
JP (1) JP3657515B2 (de)
KR (1) KR20010042225A (de)
CN (1) CN1294598A (de)
AT (1) ATE336512T1 (de)
AU (1) AU756495B2 (de)
BR (1) BR9909026A (de)
CA (1) CA2321179A1 (de)
DE (1) DE69932812T2 (de)
ES (1) ES2272065T3 (de)
HU (1) HUP0103650A3 (de)
IL (1) IL138586A0 (de)
NZ (1) NZ506553A (de)
PL (1) PL343638A1 (de)
PT (1) PT1064309E (de)
TR (1) TR200002695T2 (de)
WO (1) WO1999050301A2 (de)
ZA (1) ZA200004383B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526636D1 (de) * 1994-07-29 2002-06-13 Innogenetics Nv Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung
US20030180284A1 (en) * 1998-11-05 2003-09-25 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
CZ20021819A3 (cs) * 1999-10-27 2003-06-18 Innogenetics N. V. Oxidačně redukční reverzibilní HCV proteiny s konformací podobnou nativním proteinům
EP1535628B1 (de) * 1999-11-24 2013-07-31 Novartis Vaccines and Diagnostics, Inc. Hbv/hcv virus-ähnliche teilchen
EP1178116A1 (de) * 2000-08-03 2002-02-06 Hybrigenics S.A. Sid nukleische Saüre und aus einem pathogenischen Stamm des Hepatitis C Viruses selektierte Polypeptide und deren Verwendungenthereof
JP2004524829A (ja) * 2000-12-01 2004-08-19 アメリカ合衆国 Ｃ型肝炎ウイルスのｅ２糖タンパク質に特異的なモノクローナル抗体、ならびにｃ型肝炎の診断、治療、および予防におけるそれらの使用
US7250166B2 (en) * 2001-01-12 2007-07-31 Molecules Of Man Ab Human monoclonal antibodies that bind hepatitis C virus (HCV) E1
JP4342519B2 (ja) * 2003-09-22 2009-10-14 株式会社グリーンペプタイド Ｃ型肝炎ウイルス由来ペプチド
EP1574517A1 (de) * 2004-03-09 2005-09-14 Innogenetics N.V. HCV E1 beinhaltend spezifische Disulfidbrücken
EP1602664A1 (de) * 2004-03-08 2005-12-07 Innogenetics N.V. HCV E1 beinhaltend spezifische Disulfidbrücken
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
WO2006033012A2 (en) * 2004-09-24 2006-03-30 Pfizer Limited Method of screening for modulators of hepatitis c virus infection
WO2008150282A1 (en) * 2006-02-23 2008-12-11 University Of California, San Diego Ribosomal s-6 kinase (rsk) inhibitory peptides and method of use thereof
EP2004685A4 (de) * 2006-03-22 2009-04-29 Genimmune N V Hepatitis-c-virus-neutralisierende antikörper
WO2007137456A1 (fr) * 2006-06-01 2007-12-06 Yun Cheng Peptide pour la prévention ou le traitement d'atteinte hépatique et son dérivé ainsi que son utilisation
NZ579706A (en) 2007-02-21 2012-03-30 Univ Massachusetts Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof
DK2862876T3 (en) 2008-09-30 2016-05-23 Toray Industries Antibody binding to envelope protein 2 of hepatitis C virus and method for identifying the genotype of hepatitis C virus using the same
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
WO2014065822A1 (en) * 2012-10-26 2014-05-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus neutralizing epitopes, antibodies, and methods
EP3770604A3 (de) * 2015-03-23 2021-04-14 Essen Instruments, Inc. Durchflusszytometrieverfahren zur bewertung von biologischem material für nicht zugehörige partikel in virusgrösse vom virustyp eines influenzavirus
CN109232722B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段317-325及其用途
CN109160942B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段502-518及其用途
KR20230050761A (ko) 2021-10-08 2023-04-17 김민준 과제기한 자동알림

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308750A (en) 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
DE69131882T3 (de) 1990-11-08 2007-05-24 Novartis Vaccines and Diagnostics, Inc., Emeryville Asiloglycoproteine des hepatitis c-virus
WO1992013892A1 (en) * 1991-01-31 1992-08-20 Abbott Laboratories Monoclonal antibodies to putative hcv envelope region and methods for using same
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
WO1993015193A1 (en) 1992-01-31 1993-08-05 Abbott Laboratories Mammalian expression systems for hcv proteins
AU671623B2 (en) * 1992-03-06 1996-09-05 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and biotinylated peptides used therein
JPH05344899A (ja) 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho Ｃ型肝炎ウイルス外被タンパク質の産生法
AU667578B2 (en) * 1992-08-27 1996-03-28 Deakin Research Limited Retro-, inverso-, and retro-inverso synthetic peptide analogues
US5514539A (en) 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5610009A (en) 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
DE69526636D1 (de) 1994-07-29 2002-06-13 Innogenetics Nv Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung
US6110465A (en) * 1995-06-07 2000-08-29 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines

Also Published As

Publication number Publication date
ZA200004383B (en) 2003-01-28
HUP0103650A3 (en) 2005-10-28
TR200002695T2 (tr) 2000-12-21
JP3657515B2 (ja) 2005-06-08
HUP0103650A2 (hu) 2002-01-28
AU3602299A (en) 1999-10-18
KR20010042225A (ko) 2001-05-25
DE69932812D1 (de) 2006-09-28
DE69932812T2 (de) 2007-04-12
WO1999050301A3 (en) 1999-11-25
CA2321179A1 (en) 1999-10-07
EP1064309B1 (de) 2006-08-16
NZ506553A (en) 2002-11-26
CN1294598A (zh) 2001-05-09
PL343638A1 (en) 2001-08-27
US20030129746A1 (en) 2003-07-10
BR9909026A (pt) 2000-12-05
IL138586A0 (en) 2001-10-31
AU756495B2 (en) 2003-01-16
WO1999050301A2 (en) 1999-10-07
ES2272065T3 (es) 2007-04-16
EP1064309A2 (de) 2001-01-03
PT1064309E (pt) 2006-12-29
US6841353B2 (en) 2005-01-11
EP0947525A1 (de) 1999-10-06
US6521403B1 (en) 2003-02-18
JP2002510038A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
ATE336512T1 (de) Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe
FI870447A (fi) Htlv-iii-hoeljepeptider.
ATE374042T1 (de) Fc-fusionsproteine zur erhöhung der immunogenität von protein- und peptid-antigenen
NO994983L (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
AU2555297A (en) Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
ES2139607T3 (es) Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos.
DE69232906T2 (de) Detektion des Hepatis-C Virus.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
NO20051715L (no) HCV assay
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
KR930008155A (ko) 씨형 간염 바이러스(hcv)에 대한 모노클로날 항체
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
DE69941051D1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisier
DE69225960D1 (de) Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
KR950700423A (ko) 씨(c)형 간염 비루스에 대한 단일클론 항체 및 항-유전자형 항체(monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus)
ES2132115T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c y su procedimiento de utilizacion.
GR3029320T3 (en) Monoclonal antibodies to putative hcv ns5 proteins and methos for using same.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1064309

Country of ref document: EP

REN Ceased due to non-payment of the annual fee